Aeffe SpA
XMUN:3A1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aeffe SpA
XMUN:3A1
|
IT |
|
S
|
SynBiotic SE
XBER:SBX
|
DE |
|
C
|
Co-Diagnostics Inc
F:C97
|
US |
|
Vhm Ltd
OTC:VHMLF
|
AU |
|
Distribusi Voucher Nusantara Tbk PT
IDX:DIVA
|
ID |
Wall St Price Targets
3A1 Price Targets Summary
Aeffe SpA
According to Wall Street analysts, the average 1-year price target for 3A1 is 0.5493 EUR with a low forecast of 0.5439 EUR and a high forecast of 0.5654 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 3A1's stock price target?
Price Target
0.5493
EUR
According to Wall Street analysts, the average 1-year price target for 3A1 is 0.5493 EUR with a low forecast of 0.5439 EUR and a high forecast of 0.5654 EUR.
What is the Revenue forecast for Aeffe SpA?
Projected CAGR
-7%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 2 years is -7%.
What is the Gross Profit forecast for Aeffe SpA?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Gross Profit has been -1%. The projected CAGR for the next 5 years is 12%.
